Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship
Published in: Journal of Cancer Survivorship 1/2011

01-03-2011 | Erratum

Erratum to: An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis

Authors: Rebecca M. Speck, Kerry S. Courneya, Louise C. Mâsse, Sue Duval, Kathryn H. Schmitz

Published in: Journal of Cancer Survivorship | Issue 1/2011

Login to get access

Excerpt

Erratum to: J Cancer Surviv …
Metadata
Title
Erratum to: An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis
Authors
Rebecca M. Speck
Kerry S. Courneya
Louise C. Mâsse
Sue Duval
Kathryn H. Schmitz
Publication date
01-03-2011
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 1/2011
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-010-0137-7

Other articles of this Issue 1/2011

Journal of Cancer Survivorship 1/2011 Go to the issue

OriginalPaper

Physical activity type and intensity among rural breast cancer survivors: patterns and associations with fatigue and depressive symptoms

OriginalPaper

The relation between arm/shoulder problems and quality of life in breast cancer survivors: a cross-sectional and longitudinal study

OriginalPaper

Physical activity and health-related quality of life in young adult cancer survivors: a Canadian provincial survey

OriginalPaper

Do ongoing lifestyle disruptions differ across cancer types after the conclusion of cancer treatment?

OriginalPaper

Engaging African American breast cancer survivors in an intervention trial: culture, responsiveness and community

OriginalPaper

Exercise behavior in cancer survivors and associated factors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits